Having grown up within a Orthodox Jewish enclave, Rifky Tkatch, knew that many in her community did not like to talk about cancer. Yet it wasn’t until she conducted interviews in Detroit that she uncovered barriers to screening that stunned her.
New government breast cancer guidelines downgrade the value of screening women under 50. That could mean higher costs for millions of women with higher risks of carrying the BRCA mutations — like Ashkenazi Jews.
Should more Ashkenazi women get tested for the cancer-causing BRCA gene? Subsidized screenings are available for all — but doctors are divided on whether that’s the right approach.
No family history of breast cancer? If you’re Ashkenazi, a new study says you should get tested anyway — but some experts disagree.
A year after Angelina Jolie went public about her double mastectomy, interest in genetic testing has increased. But a worrying trend is also shaping up: unnecessary breast-removal surgeries.
Since the Supreme Court ruling one year ago, Myriad Genetics is no longer the only lab in the United States conducting BRCA testing. But it refuses to share lifesaving data it has collected.
Beatles manager Brian Epstein struggled with his sexuality and his Judaism right up until he died of a drug overdose. We discuss his legacy with the author of ‘The Fifth Beatle.’
Testing for BRCA genetic mutations, tied to breast and ovarian cancers in Jewish women, isn’t common, despite proven risks. Marcia Watson-Levy learned the danger firsthand.
Regulatory hurdles plague a new class of cancer drugs that showed encouraging results. Those obstacles have frustrated carriers of cancer-causing mutations, for whom medicine might prove helpful.
Genetics has long been thought to play a relatively minor role when it comes to the development of Parkinson’s disease. So it came as a surprise to the medical community five years ago when Dr. Susan Bressman and her colleagues at the Beth Israel Medical Center in New York reported that a single genetic mutation in a gene called LRRK2 accounted for a significant portion of all cases of Parkinson’s disease among Ashkenazi Jews.